The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL.
 
Francine M. Foss
Consulting or Advisory Role - Celgene; Eisai; Millennium; Seagen; Spectrum Pharmaceuticals; Verastem
Speakers' Bureau - Celgene; Seagen
Research Funding - Celgene
 
Christiane Querfeld
Consulting or Advisory Role - Actelion; Celgene; MiRagen
 
Youn H. Kim
Consulting or Advisory Role - Actelion; Eisai; Forty Seven; Kyowa Hakko Kirin; Medivir; Millennium; miRagen; Portola Pharmaceuticals; Seagen
Research Funding - Eisai; Forty Seven; Infinity Pharmaceuticals; Innate Pharma; Kyowa Hakko Kirin; Merck; Millennium; miRagen; Neumedicines; Seagen; Soligenix; TetraLogic Pharmaceuticals
 
Lauren C. Pinter-Brown
No Relationships to Disclose
 
Basem M. William
Honoraria - miRagen
Consulting or Advisory Role - Guidepoint Global; miRagen; Navicor
Research Funding - Celgene
 
Pierluigi Porcu
Honoraria - Actelion; Celgene
Consulting or Advisory Role - Innate Pharma
Research Funding - Celgene (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); OncoMed (Inst); Seagen (Inst)
 
Theresa Pacheco
No Relationships to Disclose
 
Bradley Haverkos
No Relationships to Disclose
 
Jennifer DeSimone
Speakers' Bureau - Actelion
Research Funding - Actelion (Inst); miRagen (Inst); Soligenix (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - actelion
 
Joan Guitart
No Relationships to Disclose
 
Ahmad Sami Halwani
Research Funding - Abbvie; Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Genentech; Immune Design; Kyowa Hakko Kirin; miRagen; Pharmacyclics; Roche/Genentech; Seagen; Takeda
Travel, Accommodations, Expenses - Abbvie; Pharmacyclics; Seagen
 
Herbert Aaron Eradat
Honoraria - Abbvie; Genentech/Roche; Gilead Sciences
Consulting or Advisory Role - Abbvie; Genentech/Roche; Gilead Sciences
Speakers' Bureau - Abbvie; Genentech/Roche; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; miRagen; Pharmacyclics; Seagen
 
Auris Huen
Consulting or Advisory Role - Kyowa Hakko Kirin; miRagen; Precision Oncology; Seagen; Seagen
Travel, Accommodations, Expenses - Galderma
 
Anita G Seto
Employment - miRagen
Stock and Other Ownership Interests - miRagen
Patents, Royalties, Other Intellectual Property - miRagen
Other Relationship - miRagen
 
Linda A Pestano
Employment - Biodesix (I); miRagen
Stock and Other Ownership Interests - Biodesix (I); Cascadian Therapeutics; miRagen; Sanofi Pasteur
Research Funding - miRagen; Servier (Inst)
Travel, Accommodations, Expenses - Biodesix (I); miRagen
 
Gilad Shalag Gordon
Employment - Orra Group
Leadership - Orra Group; TEQ Analytic Laboratories
Stock and Other Ownership Interests - amidebio; TEQ Analytic Laboratories
Consulting or Advisory Role - Agios; Bayer; Clinipace; Deciphera; Fluidigm; Globavir; HERON; igm; miRagen; Pre-Cell; Prevacept; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - milestone payments on dengue vaccine development from Takeda
Travel, Accommodations, Expenses - Orra Group
 
Diana Escolar
Employment - Akashi Therapeutics; miRagen
Leadership - Akashi Therapeutics
Stock and Other Ownership Interests - Akashi Therapeutics; miRagen
 
Paul Rubin
Employment - miRagen
Leadership - miRagen
Stock and Other Ownership Interests - miRagen
 
William S. Marshall
Employment - miRagen
Leadership - miRagen
Stock and Other Ownership Interests - miRagen
Patents, Royalties, Other Intellectual Property - Patents on microRNA modulators
Travel, Accommodations, Expenses - miRagen
 
Jud Williams
Employment - miRagen
Stock and Other Ownership Interests - Array BioPharma; Clovis Oncology; miRagen
Travel, Accommodations, Expenses - miRagen